Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00300885
Status:
TERMINATED
Last Update Posted:
2014-11-04
First Post:
2006-03-08
Brief Title:
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib BAY 43-9006 in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer NSCLC
Sponsor:
Bayer
Organization:
Bayer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
2007-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-08
First Submit QC Date:
March 8 2006
Study First Post Date:
2006-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-09-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-28
Last Update Post Date:
2014-11-04
Last Update Post Date Type:
ESTIMATED